TWST Stock Price, Chart, Stats & News

Twist Bioscience Corporation
Save
5.30B
Market cap
–
Current P/E
–
Forward P/E
TWST chart
1M
3M
1Y
5Y
Loading chart...
Fundamentals
Gross margin | 51.62% |
Operating margin | -34.35% |
Pretax margin | -19.34% |
Net margin | -19.56% |
Effective tax rate | -1.16% |
ROA | -12.00% |
ROE | -16.58% |
D/E | 0.40x |
Interest coverage ratio | -940.66x |
TWST valuation
P/E | – |
P/S | 6.97x |
P/B | 5.96x |
P/CF | -53.32x |
P/FCF | -31.48x |
P/OCF | -53.32x |
PEG | -15.39x |
EV multiple | -52.67x |
About
Twist Bioscience Corporation operates as a leading synthetic biology firm, specializing in the production and sale of products developed from synthesized DNA. The company utilizes a unique DNA synthesis platform that facilitates the creation of artificial DNA by "writing" it directly onto silicon chips. Its extensive product catalog encompasses custom synthetic genes, specialized tools designed for sample preparation, comprehensive antibody libraries essential for pharmaceutical research and development, and advanced applications leveraging DNA for digital data storage.
Similar securities
Based on sector and market capitalization
Report issue











